Vital Innovations Posts Zero Revenue but Narrows 1H26 Loss; Cash Position Rebounds to RMB42.38 Million

Bulletin Express
Sep 21

Vital Innovations Holdings Limited reported no revenue for the six months ended 30 June 2026 (1H26), a sharp reversal from RMB449.01 million in the prior-year period, as management halted shipments of smartphones and LED products to avoid loss-making transactions amid surging memory and logistics costs.

Operating metrics • Gross profit fell to nil from RMB1.73 million a year earlier. • Operating loss narrowed 25% year on year to RMB6.26 million (1H25: RMB8.42 million) through reductions in rent, headcount and freight expenses. • Finance costs decreased 66.5% to RMB0.28 million, reflecting lower bank borrowings. • Loss per share improved to RMB0.74 versus RMB0.99 in 1H25; no interim dividend was declared.

Balance-sheet movements • Cash and bank balances surged to RMB42.38 million from RMB2.14 million at end-2025, aided by a RMB40.63 million operating cash inflow. • Current ratio improved to 5.6x (31 Dec 2025: 5.1x). • Bank loans declined to RMB2.33 million; gearing slid to 0.51% (31 Dec 2025: 0.64%). • Prepayments and deposits remained sizeable at RMB467.42 million, including a RMB147.00 million refundable deposit to secure handset supply. • Trade and other receivables fell 29.0% to RMB46.60 million, mainly from customer settlements.

Audit disclaimer and risk factors Confucius International CPA Limited issued a disclaimer of opinion on the FY25 accounts, citing: 1) material uncertainty over going-concern due to prior-year net loss and liquidity pressures; 2) inability to verify RMB359.96 million in supplier prepayments and RMB150.00 million refundable deposit; 3) insufficient evidence on the recoverability of RMB54.01 million overdue trade receivables.

Management has since recovered RMB46 million of prepayments/deposits and RMB18.80 million of trade receivables (post-1 Jan 2026). Measures under way include intensified collection efforts, legal action, cost controls and potential financial support from major shareholders. The Audit Committee is monitoring progress and reinforcing internal controls, particularly for prepayment approvals exceeding RMB20 million.

Strategic shifts With smartphone margins compressed by component inflation—especially DRAM/NAND—and muted global demand, Vital Innovations is prioritising: • Artificial intelligence and satellite-enabled devices; • Humanoid and industrial robotics; • Higher-margin LED products introduced in 2025.

Industry outlook Market trackers project a 12.4%–13.9% decline in global smartphone shipments for full-year 2026, driven by component shortages and higher bill-of-materials costs. While premium and foldable devices show relative resilience, budget segments—core to Vital Innovations’ historical portfolio—remain under pressure.

Management guidance The Board maintains a “cautiously optimistic” stance for 2H26, focusing on stabilising the handset business, accelerating LED and AI-linked initiatives, and restoring liquidity through receivable and deposit recoveries. No material acquisitions, disposals or dividends are planned, and the company confirms compliance with Hong Kong listing public-float requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10